Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (4217)

Showing 12 of 4217 View All
Showing 209 of 352 pages

The world's last smallpox patient

Smallpox was one of the deadliest diseases in the world, but it’s the only one in history to have been eradicated globally. One Somali man sat on the frontline of this effort and can inspire the world today as we battle yet another devastating…

What are 'adverse events' and 'emergency use authorisation' in relation to vaccination?

While vaccines are the safest way to prevent the spread of infectious disease, a tiny proportion of those vaccinated may experience an adverse event. Here, we explain how often this happens and why.

Here’s how we could stop antimicrobial resistance becoming the next pandemic

Antimicrobial resistance was already a major global health threat, but now the potential increase in the use of antibiotics in response to the pandemic could exacerbate the problem and threaten a potentially even bigger global crisis.

What’s the most effective face mask for preventing COVID-19 transmission?

Face coverings have become a standard feature of pandemic life, but which mask is best for everyday use, and how should you take care of it?

Protecting Lower-Income Countries with COVID-19 Vaccines Requires Global Solidarity

The medical and moral imperative for equitable access to COVID-19 vaccines is why COVAX was created. Co-led by Gavi, the Vaccine Alliance, together with the World Health Organization (WHO) and the Coalition for Epidemic Preparedness…

4 things about mRNA COVID vaccines researchers still want to find out

Researchers are already working to improve the current crop of mRNA vaccines. Hopefully this will help them become more practical and affordable for the entire world, not just first-world countries.

How COVID-19 is altering cold and flu seasons

Pandemic restrictions and wider use of flu vaccines may have explained 2020’s record low cases of seasonal flu, but will the picture look like in tropical countries with year-round flu?

COVAX Statement on New Variants of SARS-CoV-2

The emergence of variants of SARS-CoV-2, the virus that causes COVID-19, serve as a powerful reminder that viruses by their very nature mutate, and that the scientific response may need to adapt if they are to remain effective against them.

How the Oxford-AstraZeneca vaccine could still help the battle against the COVID-19 variant

Research suggesting that one of the COVID-19 vaccines provides only minimal protection against mild-moderate infection caused by the 501.Y.V2 variant has raised concerns. But this doesn’t mean it won’t prevent severe disease and deaths.

Eliminating cervical cancer depends on global effort to ensure supply meets demand

Global access to HPV vaccine is vital, particularly in lower-income countries. Lessons learned from HPV roll-out could boost uptake of COVID-19 vaccines.

Why even a low efficacy COVID-19 vaccine could still be extremely useful

Efficacy rates for COVID-19 vaccines are higher than many scientists had dared dream of, but even if they prove less effective in real life, or in the face of new variants, they could still unlock normal life.

Who can’t have a COVID-19 vaccine?

The currently available coronavirus vaccines have been tested on adults of various ages, as well as those with long-term conditions, and appear to be safe. But there are a few groups who should avoid being vaccinated for now.

Subscribe to our newsletter